Press Releases

• Aligos Therapeutics: Presents Positive Data at HEP-DART 2025 More
• Autobahn Labs: Forms Strategic Partnership With Astellas to Accelerate Academic Discoveries into New Medicines More
• BBOT: Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS) More
• Bio Usawa: Welcomes Global Health Strategist, Professor Prashant Yadav, as Chair of Its Global Access and Health Equity Advisory Board More
• Brii Biosciences and OpenBench: AI-Driven Collaboration for Proprietary Technology Platform More
• Cerus: Group Purchasing Agreement With Blood Centers of America More
• Guardant Health: Collaboration With Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. More
• HanchorBio: Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 More
• IDEAYA Biosciences: Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination With Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma More
• Illumina and MyOme: Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually More
• Intuitive: Expanded Indications for da Vinci SP More
• Lumosity: FDA Clearance of LumosityRx, a Prescription Digital Therapeutic for Adults With ADHD More
• Personalis: New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer More
• Quince Therapeutics: Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders More
• Rezolute: Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism More More
• Science: Names Darius Shahida as Chief Strategy Officer More

Financial News

• Exclusive VC Funding Data from BYTE51, with Special Big4Bio Pricing More
• JPM Week Conference Readiness Packages (Big4Bio Subscriber Discount) More
• Medra: Raises $52 Million Series A to Build Physical AI Scientists More
• Mirum Pharmaceuticals: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Prolynx: Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer More More More* More* 
• Subsense: Expands Financing to $27 Million to Accelerate R&D for Non-Surgical Brain-Computer Interfaces More
• Valinor: Raises $13 Million to Increase Clinical Trial Success Rates With Proprietary ML Models More

Media/Misc Coverage

• Curve Biosciences Looks to Grow As It Moves HQ From San Mateo to Dallas More*
  
• Gladstone: Genomic Maps Untangle the Complex Roots of Disease More
  
• Subscribe to LifeSci Startup for Updates on US Startups More 
• The Big4Bio Podcast: Every Moment Matters: Integrating AI into Drug Discovery Podcast
• The Bioentrepreneurs: Stanford, UCSF, Berkeley - December 2025 Updates More

Companies

Career Center

• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
• ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• ICYMI: The Power of Peer Learning - Why Even Top Biotech Leaders Need Mentorship More
• ICYMI: What’s Next in Precision Medicine: Leadership Challenges and Opportunities More
• The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More

• Trade and Channel Strategies (Save 10% with VIP code: 25B4B10) Dec 9-11
  
• Advancing Drug Development Forum Dec 11
• Know Before You Go: AI in 2026 — Signals, Risks, and Real-World Impact (Pre-JPM Event) Jan 6
• BLPN Investor Summit Jan 8-10

SF Bay Sponsors